RULE NO: RULE TITLE
64C-7.001: Definitions
64C-7.002: Collection Procedures for Metabolic Screening
64C-7.0026: Administration of Newborn Hearing Screening

Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 34 No. 1, January 4, 2008 issue of the Florida Administrative Weekly.

The following changes have been made following recommendations from the Joint Administrative Procedures Committee:

64C-7.001 Definitions.

(1) “Advisory councils” means the Genetics and Newborn Infant Screening Advisory Council established by Section 383.14, F.S. and the State Coordinating Council for Early Childhood Services established by Section 411.222, F.S.

(10) “Hearing risk factors” means selected risk factors having the potential to result in late onset hearing loss which are: family history, low birth weight (less than 1500 grams), PPHN (persistent pulmonary hypertension of a newborn), ECMO (extra corporeal membrane oxygenation), and hyperbilirubinemia or exchange transfusion.

64C-7.002 Collection Procedures for Newborn Metabolic Screening.

(2) The infant's blood shall be collected on a specimen slip, DOH Form DH 677, (Revised 11/07) (Jan 93), which is titled “Infant Screening Metabolic Disorders” and incorporated by reference. The form may be obtained through the State Public Health Laboratory located at 1217 North Pearl Street, Jacksonville, FL 32202. Forms may also be ordered through the any DOH website at http://www.doh.state.fl.us/PDF_Files/OrderForm_for_DH677.pdf County Health Department. The slip with blood and completed data must be inserted into the protective envelope and mailed to an approved laboratory within 24 hours after collection.

64C-7.0026 Administration of Newborn Hearing Screening.

(1) The hospital must record the latest hearing screening results on DOH Form DH 677, (Revised 11/07), which is titled “Infant Screening Metabolic Disorders” and incorporated by reference.